NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Study of Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients

Not Applicable

Terminated

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2016-12-14

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Registration Number: NCT00000824

Locations: 🇺🇸
Stanford Univ School of Medicine, Stanford, California, United States

A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-29

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 475

Registration Number: NCT00000912

Locations: 🇺🇸
USC Univ Hosp & Ambulatory Hlth Care Ctr / USC Med Ctr, Los Angeles, California, United States
🇺🇸
Emory Univ, Atlanta, Georgia, United States
🇺🇸
UCLA CARE Ctr, Los Angeles, California, United States

and more 42 locations

Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection

Not Applicable

Terminated

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2016-12-14

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 16

Registration Number: NCT00000875

Locations: 🇺🇸
The Ctr For Blood Research Inc, Boston, Massachusetts, United States

A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine

Phase 3

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-03

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 250

Registration Number: NCT00000720

Locations: 🇺🇸
Los Angeles County - USC Med Ctr, Los Angeles, California, United States
🇺🇸
Cedars Sinai / UCLA Med Ctr, Los Angeles, California, United States
🇺🇸
Univ of Connecticut Health Ctr / Pediatrics, Farmington, Connecticut, United States

and more 48 locations

Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS

Phase 3

Completed

Conditions: Pneumonia, Pneumocystis Carinii
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 364

Registration Number: NCT00001013

Locations: 🇺🇸
Tulane Univ School of Medicine, New Orleans, Louisiana, United States
🇺🇸
Charity Hosp / Tulane Univ Med School, New Orleans, Louisiana, United States
🇺🇸
SUNY / State Univ of New York, Syracuse, New York, United States

and more 20 locations

Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 240

Registration Number: NCT00001083

Locations: 🇺🇸
Harbor - UCLA Med Ctr / UCLA School of Medicine, Los Angeles, California, United States
🇺🇸
Univ of Miami (Pediatric), Miami, Florida, United States
🇺🇸
North Shore Univ Hosp, Great Neck, New York, United States

and more 58 locations

Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-03

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 20

Registration Number: NCT00000728

Locations: 🇺🇸
Stanford Univ School of Medicine, Stanford, California, United States

Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 92

Registration Number: NCT00006066

Locations: 🇺🇸
Nyu Ny Nichd Crs, New York, New York, United States
🇺🇸
Children's National Med. Ctr. Washington DC NICHD CRS, Washington, District of Columbia, United States
🇺🇸
Usc La Nichd Crs, Los Angeles, California, United States

and more 11 locations

A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children

Phase 3

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 819

Registration Number: NCT00000637

Locations: 🇺🇸
Children's Med Ctr of Dallas, Dallas, Texas, United States
🇺🇸
Univ of Maryland at Baltimore / Univ Med Ctr, Baltimore, Maryland, United States
🇺🇸
UCLA Med Ctr / Pediatric, Los Angeles, California, United States

and more 77 locations

A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 6

Registration Number: NCT00001108

Locations: 🇺🇸
Cook County Hosp, Chicago, Illinois, United States
🇺🇸
Univ of Massachusetts Med School, Worcester, Massachusetts, United States
🇺🇸
Univ of Mississippi Med Ctr, Jackson, Mississippi, United States

and more 16 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy